Onesource Specialty Pharma

Onesource Specialty Pharma Receivables Turnover

The Receivables Turnover Ratio of Onesource Specialty Pharma (ONESOURCE.NS) as of Oct 26, 2026 is 3.42. In the previous year, Receivables Turnover Ratio was 3.11 — a change of 9.81% (higher).

Receivables Turnover

3.42

YoY

9.81%

Last updated:

Receivables Turnover Ratio of Onesource Specialty Pharma is 2025 3.42 . Receivables Turnover Ratio of Onesource Specialty Pharma was 2024 3.11 . It decreases by 9.81% higher compared to the previous year.

The Onesource Specialty Pharma Receivables Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables Turnover
Date
Receivables Turnover
Jan 1, 2023
10.13 INR
Jan 1, 2024
3.11 INR
Jan 1, 2025
3.42 INR
The Onesource Specialty Pharma Receivables Turnover history
YEARReceivables TurnoverYoY
3.42+9.81%
3.11-69.27%
10.13—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma Ltd operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO) within the Life Sciences Tools & Services industry. Based in Bangalore, Karnataka, the India-based company provides vertically integrated biopharma services, focusing on the development and manufacture of complex biologics, biosimilars, and vaccines. Its core offerings include prefilled syringes with or without safety devices, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors. The firm supports the development of complex biologics such as microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and ribonucleic acid (RNA) products. The company generates revenue by catering to a variety of capsule shapes and sizes through its integrated services. These services encompass formulations ranging from traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and su. By providing comprehensive biologics solutions, the firm serves clients requiring advanced manufacturing capabilities for diverse pharmaceutical delivery systems and therapeutic modalities. Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onesource Specialty Pharma stock

Receivables Turnover Ratio of Onesource Specialty Pharma is 3.42 in 2025.

Receivables Turnover Ratio of Onesource Specialty Pharma changed from 3.11 to 3.42, representing a 9.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Receivables Turnover Ratio Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

Receivables turnover measures how efficiently a company collects its receivables. Higher turnover indicates faster collection.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Receivables Turnover Ratio's Onesource Specialty Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Receivables Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Receivables Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Onesource Specialty Pharma

All Key Metrics — Onesource Specialty Pharma